SeraCare™ Anti-HIV-1 Low Titer Performance Panels [Modified]

Description

For the evaluation of HIV test systems

Panel of undiluted plasma samples collected from multiple donors; includes members with anti-HIV-1 reactivity near the sensitivity limit and one member negative for anti-HIV-1, included as a nonreactive control

• Extensive array of panels helps labs maintain the highest standards for assay validation, regulatory compliance and method development
• Each panel includes comprehensive, comparative data from a variety of methods and commercially available test kits, allowing reagent assay/platform performance, sensitivity and specificity to be independently challenged
• Assembled from highly characterized, disease state patient samples, and developed specifically for infectious disease testing
• Enables labs to evaluate, monitor and troubleshoot test and staff performance
• Minimizes down time and accelerates validation and verification of new test methods, reagent systems and platforms

• Rigorously tested and characterized using highest-quality test methods
• Comprehensive test results provided with each panel; quantified against international standards when available
• Long-term stability and availability
• SeraCare facilities are ISO 9001 and 13485 certified and comply with cGMP standards

Specifications

• Content And Storage: -10°C
• Format: Panel
• Type: Anti-HIV-1 low Titer Performance Modified Panel
• Includes: 10 Aliquots of Plasma units: 9 members have Anti-HIV 1 reactivity near the sensitivity limits of Anti-HIV screening tests, one specimen negative for Anti-HIV 1 as a nonreactive control
• Intended Use: Evaluating HIV test system using well characterized specimens, to provide comprehensive data for comparative analysis
• Quantity: 10 x 1 mL